logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up.

    Article - En anglais

    A two-dose vaccination program against measles, mumps, and rubella (MMR) viruses was started in Finland in 1982.

    In this program the trivalent MMR-II vaccine (MSD, USA) was offered to children at the ages of 14-18 months and 6 years followed by revaccination 4-5 years later.

    The vaccination coverage has been high (97%) and MMR infections have practically been eliminated in the Finnish population.

    In a serological follow-up program sequential serum samples were obtained from 254 children (127 14-18-month-old vaccinees and 127 6-year-old vaccinees) during a 9-year follow-up period.

    Anti-mumps virus antibody titers were determined by enzyme immunoassay using purified whole mumps viruses as the antigen.

    In seronegative (n=120) 14-18-month-old vaccinees the seroconversion rate was 86% (geometric mean titer 1/1670 ± 1/270).

    The antibody levels fell rapidly (significance p<0.01) within the first year of follow-up (mean titer 1/1080 ± 1/190), but remained relatively stable in subsequent years.

    After revaccination the seropositivity rate was 95% (mean titer 1/2310 ± 1/260) and declined more slowly thereafter to 86% (mean titer 1/1510 ± 1/210) at year 9 of follow-up.

    The mean antibody titer was significantly (p<0.05) higher 4 years after the second MMR vaccination when compared with the corresponding time point after the first vaccination.

    In 6-year-old seronegative vaccinees the increase and decay of anti-mumps virus antibodies after the first MMR vaccination was s...

    Mots-clés Pascal : Paramyxovirus ourlien, Paramyxovirus, Paramyxoviridae, Virus, Oreillons, Virose, Infection, Vaccination, Réponse immune, Immunité humorale, Anticorps, Sérologie, Etude longitudinale, Enfant, Homme, Finlande, Europe

    Mots-clés Pascal anglais : Mumps paramyxovirus, Paramyxovirus, Paramyxoviridae, Virus, Mumps, Viral disease, Infection, Vaccination, Immune response, Humoral immunity, Antibody, Serology, Follow up study, Child, Human, Finland, Europe

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0186587

    Code Inist : 002A05C07. Création : 199608.